UB Paderborn / Katalog / Suche / in CDI

1 – 19 von 19

Sortiert nach

Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951

Journal of clinical oncology, 2013-01, Vol.31 (3), p.344-350

2013

Link zum Volltext

Verfügbarkeit prüfen

Health-Related Quality of Life in a Randomized Phase III Study of Bevacizumab, Temozolomide, and Radiotherapy in Newly Diagnosed Glioblastoma

Journal of clinical oncology, 2015-07, Vol.33 (19), p.2166-2175

2015

Link zum Volltext

Verfügbarkeit prüfen

Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034

Journal of clinical oncology, 2009-03, Vol.27 (8), p.1268-1274

2009

Link zum Volltext

Verfügbarkeit prüfen

Compromised Health-Related Quality of Life in Patients With Low-Grade Glioma

Journal of clinical oncology, 2011-11, Vol.29 (33), p.4430-4435

2011

Link zum Volltext

Verfügbarkeit prüfen

Cognitive Rehabilitation in Patients With Gliomas: A Randomized, Controlled Trial

Journal of clinical oncology, 2009-08, Vol.27 (22), p.3712-3722

2009

Link zum Volltext

Verfügbarkeit prüfen

MGMT Promoter Methylation Is Prognostic but Not Predictive for Outcome to Adjuvant PCV Chemotherapy in Anaplastic Oligodendroglial Tumors: A Report From EORTC Brain Tumor Group Study 26951

Journal of clinical oncology, 2009-12, Vol.27 (35), p.5881-5886

2009

Link zum Volltext

Verfügbarkeit prüfen

Health-Related Quality of Life in Patients Treated for Anaplastic Oligodendroglioma With Adjuvant Chemotherapy: Results of a European Organisation for Research and Treatment of Cancer Randomized Clinical Trial

Journal of clinical oncology, 2007-12, Vol.25 (36), p.5723-5730

2007

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Value of Health-Related Quality-of-Life Data in Predicting Survival in Patients With Anaplastic Oligodendrogliomas, From a Phase III EORTC Brain Cancer Group Study

Journal of clinical oncology, 2007-12, Vol.25 (36), p.5731-5737

2007

Link zum Volltext

Verfügbarkeit prüfen

Neurobehavioral Status and Health-Related Quality of Life in Newly Diagnosed High-Grade Glioma Patients

Journal of clinical oncology, 2001-10, Vol.19 (20), p.4037-4047

2001

Link zum Volltext

Verfügbarkeit prüfen

Reply to M.C. Chamberlain

Journal of clinical oncology, 2016-01, Vol.34 (3), p.292-293

Taphoorn, Martin J B

2016

Link zum Volltext

Verfügbarkeit prüfen

Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors

Journal of clinical oncology, 2022-08, Vol.40 (23), p.2539-2545

2022

Link zum Volltext

Verfügbarkeit prüfen

Health-related quality of life in stable, long-term survivors of low-grade glioma

Journal of clinical oncology, 2015-03, Vol.33 (9), p.1023-1029

2015

Link zum Volltext

Verfügbarkeit prüfen

Reply to T.J. Kruser et al

Journal of clinical oncology, 2016-04, Vol.34 (11), p.1282-1283

2016

Link zum Volltext

Verfügbarkeit prüfen

Final results of the EORTC Brain Tumor Group randomized phase II TAVAREC trial on temozolomide with or without bevacizumab in 1st recurrence grade II/III glioma without 1p/19q co-deletion

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.2009-2009

2017

Link zum Volltext

Verfügbarkeit prüfen

EORTC 26101 phase III trial exploring the combination of bevacizumab and lomustine in patients with first progression of a glioblastoma

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.2001-2001

2016

Link zum Volltext

Verfügbarkeit prüfen

Joint modeling of longitudinal health-related quality of life (HRQoL) data and survival

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.2034-2034

2014

Link zum Volltext

Verfügbarkeit prüfen

Radiation therapy and concurrent plus adjuvant temsirolimus (CCI-779) versus chemoirradiation with temozolomide in newly diagnosed glioblastoma without methylation of the MGMT gene promoter

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.2003-2003

2014

Link zum Volltext

Verfügbarkeit prüfen

In Reply

Journal of clinical oncology, 2008-04, Vol.26 (12), p.2062-2062

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 19 von 19

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieJournal Of Clinical Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(19)

Sprache

Englisch
(19)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Humans
(14)
Life Sciences & Biomedicine
(12)
Oncology
(12)
Science & Technology
(12)
Female
(10)
Male
(10)
Middle Aged
(10)
Biological And Medical Sciences
(8)
Medical Sciences
(8)
Neurology
(8)
Quality Of Life
(8)
Tumors Of The Nervous System. Phacomatoses
(8)
Adult
(7)
Brain Neoplasms - Drug Therapy
(7)
Tumors
(7)
Brain Neoplasms - Therapy
(6)
Oligodendroglioma - Drug Therapy
(5)
Aged
(4)
Cancer Research
(4)
Chemotherapy, Adjuvant
(4)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB-FREE-00999 freely available EZB journals
(19)
WK Lippincott Williams & Wilkins–Connect here FIRST to enable access
(19)
NUS Single-Journal Subscriptions
(19)
MEDLINE
(14)
IngentaConnect Journals
(12)
Ingenta
(12)

1 weiteren anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951

Health-Related Quality of Life in a Randomized Phase III Study of Bevacizumab, Temozolomide, and Radiotherapy in Newly Diagnosed Glioblastoma

Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034

Compromised Health-Related Quality of Life in Patients With Low-Grade Glioma

Cognitive Rehabilitation in Patients With Gliomas: A Randomized, Controlled Trial

Adjuvant Procarbazine, Lomustine, and Vincristine Improves Progression-Free Survival but Not Overall Survival in Newly Diagnosed Anaplastic Oligodendrogliomas and Oligoastrocytomas: A Randomized European Organisation for Research and Treatment of Cancer Phase III Trial

MGMT Promoter Methylation Is Prognostic but Not Predictive for Outcome to Adjuvant PCV Chemotherapy in Anaplastic Oligodendroglial Tumors: A Report From EORTC Brain Tumor Group Study 26951

Health-Related Quality of Life in Patients Treated for Anaplastic Oligodendroglioma With Adjuvant Chemotherapy: Results of a European Organisation for Research and Treatment of Cancer Randomized Clinical Trial

Prognostic Value of Health-Related Quality-of-Life Data in Predicting Survival in Patients With Anaplastic Oligodendrogliomas, From a Phase III EORTC Brain Cancer Group Study

Neurobehavioral Status and Health-Related Quality of Life in Newly Diagnosed High-Grade Glioma Patients

Reply to M.C. Chamberlain

Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors

Health-related quality of life in stable, long-term survivors of low-grade glioma

Reply to T.J. Kruser et al

Final results of the EORTC Brain Tumor Group randomized phase II TAVAREC trial on temozolomide with or without bevacizumab in 1st recurrence grade II/III glioma without 1p/19q co-deletion

EORTC 26101 phase III trial exploring the combination of bevacizumab and lomustine in patients with first progression of a glioblastoma

Joint modeling of longitudinal health-related quality of life (HRQoL) data and survival

Radiation therapy and concurrent plus adjuvant temsirolimus (CCI-779) versus chemoirradiation with temozolomide in newly diagnosed glioblastoma without methylation of the MGMT gene promoter

In Reply

Aktive Filter

Suchergebnisse filtern